NASDAQ:TRIB

Trinity Biotech (TRIB) Stock Price, News & Analysis

$1.85
+0.02 (+1.09%)
(As of 04/24/2024 ET)
Today's Range
$1.83
$1.91
50-Day Range
$0.45
$2.60
52-Week Range
$1.79
$5.50
Volume
11,196 shs
Average Volume
79,057 shs
Market Capitalization
$14.10 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
TRIB stock logo

About Trinity Biotech Stock (NASDAQ:TRIB)

Trinity Biotech plc acquires, together with its subsidiaries, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious diseases, such as lyme disease; sexually transmitted diseases consisting syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes. It also provides laboratory-testing services for Sjogren's syndrome, hearing loss, celiac disease, lupus, rheumatoid arthritis, systemic sclerosis, and other laboratory-testing services for autoimmune disorders. The company develops, manufactures, and sells products in the immunofluorescence assay, enzyme-linked immunosorbent, western blot, and line immunoassay formats; and provides reagent products, such as ACE, bile acids, lactate, oxalate, and glucose-6-phosphate dehydrogenase for diagnosis of liver and kidney diseases, as well as haemolytic anaemia. In addition, the company sells raw materials to the life sciences industry and research institutes. It serves public health authorities, non-governmental organisations, and clinical and reference laboratories through its direct sales force, as well as through a network of independent distributors and strategic partners. Trinity Biotech plc was incorporated in 1992 and is headquartered in Bray, Ireland.

TRIB Stock Price History

TRIB Stock News Headlines

Exposed: 10 CENT Crypto to Explode April 20th?
Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin
Exposed: 10 CENT Crypto to Explode April 20th?
Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin
What Wall Street expects from Trinity Biotech's earnings
TRIB Mar 2024 2.500 put
Trinity Biotech to Present at Emerging Growth Conference
See More Headlines
Receive TRIB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Trinity Biotech and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
1/31/2024
Today
4/24/2024
Next Earnings (Estimated)
7/04/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostic substances
Sub-Industry
N/A
Current Symbol
NASDAQ:TRIB
Employees
398
Year Founded
1992

Profitability

Net Income
$-24,020,000.00
Pretax Margin
-64.98%

Debt

Sales & Book Value

Annual Sales
$56.83 million
Book Value
($3.14) per share

Miscellaneous

Free Float
6,997,000
Market Cap
$13.94 million
Optionable
Optionable
Beta
1.21

Social Links

7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

  • Mr. John Gillard (Age 43)
    President, CEO, Company Secretary & Director
    Comp: $863k
  • Mr. Ronan O'Caoimh (Age 68)
    Founder & Director
    Comp: $340k
  • Dr. James Walsh Ph.D. (Age 66)
    Executive Director of Business Development & Executive Director
    Comp: $20k
  • Mr. Des Fitzgerald
    Interim Chief Financial Officer
  • Mr. Simon Dunne (Age 50)
    Chief Accounting Officer
  • Dr. Gary Keating Ph.D. (Age 51)
    Chief Technology Officer
  • Ms. Eibhlin Kelly (Age 40)
    Chief Information Officer
  • Mr. Colm Molloy (Age 53)
    Group Director of Human Resources & Culture

TRIB Stock Analysis - Frequently Asked Questions

How have TRIB shares performed in 2024?

Trinity Biotech's stock was trading at $2.1450 at the beginning of the year. Since then, TRIB shares have decreased by 13.8% and is now trading at $1.85.
View the best growth stocks for 2024 here
.

Are investors shorting Trinity Biotech?

Trinity Biotech saw a decrease in short interest during the month of March. As of March 31st, there was short interest totaling 1,200 shares, a decrease of 72.1% from the March 15th total of 4,300 shares. Based on an average daily trading volume, of 93,300 shares, the days-to-cover ratio is presently 0.0 days. Currently, 0.0% of the company's shares are short sold.
View Trinity Biotech's Short Interest
.

When is Trinity Biotech's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, July 4th 2024.
View our TRIB earnings forecast
.

How were Trinity Biotech's earnings last quarter?

Trinity Biotech plc (NASDAQ:TRIB) posted its earnings results on Wednesday, January, 31st. The company reported ($0.90) earnings per share for the quarter. The company earned $14.68 million during the quarter.

When did Trinity Biotech's stock split?

Trinity Biotech shares reverse split on Wednesday, February 21st 2024. The 1-5 reverse split was announced on Wednesday, February 21st 2024. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, February 21st 2024. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

What is Ronan O'Caoimh's approval rating as Trinity Biotech's CEO?

20 employees have rated Trinity Biotech Chief Executive Officer Ronan O'Caoimh on Glassdoor.com. Ronan O'Caoimh has an approval rating of 8% among the company's employees. This puts Ronan O'Caoimh in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Trinity Biotech own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Trinity Biotech investors own include Gilead Sciences (GILD), Novavax (NVAX), OPKO Health (OPK), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Netflix (NFLX), Pfizer (PFE), QUALCOMM (QCOM), Energy Transfer (ET) and Exxon Mobil (XOM).

How do I buy shares of Trinity Biotech?

Shares of TRIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:TRIB) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners